APA (7th ed.) Citation

Lavoz, C., Rayego-Mateos, S., Orejudo, M., Opazo-Ríos, L., Marchant, V., Marquez-Exposito, L., . . . Ruiz-Ortega, M. (2020). Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy? Journal of Clinical Medicine, 9(1), 272. https://doi.org/10.3390/jcm9010272

Chicago Style (17th ed.) Citation

Lavoz, Carolina, et al. "Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?" Journal of Clinical Medicine 9, no. 1 (2020): 272. https://doi.org/10.3390/jcm9010272.

MLA (9th ed.) Citation

Lavoz, Carolina, et al. "Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?" Journal of Clinical Medicine, vol. 9, no. 1, 2020, p. 272, https://doi.org/10.3390/jcm9010272.